Concepedia

Publication | Open Access

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy

DOIFull Paper Access

24

Citations

38

References

2022

Year

Antonio Nieto, Ángel Mazón, María Nieto, Ethel Ibáñez-Echevarría, Dah Tay Jang, Susana Calaforra, Pilar Alba, Carmen Pérez‐Francés, Ruth Llusar, Javier Montoro,
Allergy

Abstract

PM-HDM immunotherapy was safe and successful in achieving primary and secondary clinical outcomes in SC and SL at either 3000 or 5000 mTU/ml.

References

YearCitations

Page 1